Top compounds associated with response to TYK2


Feature Type Standardized
Nominal ANOVA
mRNA sotrastaurin CTRPv2 pan-cancer AAC 0.25 8e-07
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-06
mRNA AT-406 CTRPv2 pan-cancer AAC 0.28 5e-06
mRNA barasertib CTRPv2 pan-cancer AAC 0.19 8e-06
mRNA R428 CTRPv2 pan-cancer AAC 0.24 1e-05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 8e-05
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 0.0001
mRNA TPCA-1 CTRPv2 pan-cancer AAC 0.16 0.0002
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 0.0002
Download CSV